DNA
Ginkgo Bioworks Holdings, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +27.3% ·
aliran saham +2.7% ·
posisi baru bersih +20.0%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | +5 | 25.52M | $252.75M | +9 | −4 |
| Q1 2026 | 72 | -1 | 23.15M | $141.95M | +6 | −7 |
| Q4 2025 | 73 | +2 | 24.08M | $200.09M | +2 | — |
| Q3 2025 | 15 | -2 | 16.22M | $236.55M | — | −2 |
| Q2 2025 | 14 | 0 | 15.99M | $179.94M | +2 | −2 |
| Q1 2025 | 11 | -3 | 10.22M | $58.26M | — | −3 |
| Q4 2024 | 14 | +3 | 10.20M | $100.21M | +3 | — |
| Q3 2024 | 10 | -3 | 9.70M | $79.02M | — | −3 |
| Q2 2024 | 13 | — | 419.17M | $140.02M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 3.58M | 0.0% | $35.13M | 0.1% | Held | 3 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 3.36M | 0.0% | $32.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 3.36M | 0.0% | $32.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 3.36M | 0.0% | $32.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 3.36M | 0.0% | $32.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Millennium Management ✦ | 670.07K | +357.4% | $6.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 645.36K | -2.1% | $6.34M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 546.42K | -37.4% | $5.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (pasif) | 437.02K | +4.9% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (pasif) | 437.02K | +4.9% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (pasif) | 238.83K | — | $2.35M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Glenview Capital ✦ | 187.50K | -60.5% | $1.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 141.74K | Baru | $1.39M | 0.0% | New | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 114.65K | +65.1% | $1.13M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 99.80K | Baru | $980,036 | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 82.81K | +4.0% | $814,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 82.81K | +4.0% | $814,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 67.68K | Baru | $664,657 | 0.0% | New | 1 | SEC ↗ |
| 19 | Marshall Wace ✦ | 67.68K | Baru | $664,657 | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 37.61K | -7.0% | $369,359 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 37.61K | -7.0% | $369,359 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 37.61K | -7.0% | $369,359 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Citadel Advisors | $1.39M | 0.0% |
| Point72 Asset Management | $980,036 | 0.0% |
| Marshall Wace | $664,657 | 0.0% |
| Marshall Wace | $664,657 | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 140 saham, $0 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 330 lbr · $2,302
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi